New diagnosis code for patients with type 2 diabetes in remission

Use lifestyle interventions to show no signs of type 2 diabetes for at least three months? There's a code for that: E11.A.
AHA/ASA Journals

Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort

BACKGROUND: Cardiac and vascular complications are the leading causes of maternal mortality and morbidity, but the ...
Pulmonology Advisor

ACE Inhibitors May Reduce All-Cause Mortality in Idiopathic Pulmonary Fibrosis

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.
The Cardiology Advisor

Vasopressor and IABP Use Higher in Patients With GDM, PPCM

Researchers sought to assess outcomes following peripartum cardiomyopathy among patients with gestational diabetes.

FDA approves Jascayd for idiopathic pulmonary fibrosis

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis ...
The American Journal of Managed Care

Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
Healio

Biologics lower rate of admissions requiring noninvasive ventilation in COPD

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...
Pulmonology Advisor

Jascayd Receives FDA Approval for Idiopathic Pulmonary Fibrosis

The Food and Drug Administration has approved Jascayd for the treatment of idiopathic pulmonary fibrosis in adult patients.
EurekAlert!

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related ...
The Lancet

Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver Diseases

Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...